|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/7024 | (2006.01) |
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 1446131 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02787601.0 |
| Date of filing the European patent application | 2002-11-07 | |
| (97) | Date of publication of the European application | 2004-08-18 |
| (45) | Date of publication and mention of the grant of the patent | 2007-05-09 |
| (46) | Date of publication of the claims translation | 2007-09-25 |
| (86) | Number | PCT/EP2002/012482 |
| Date | 2002-11-07 |
| (87) | Number | WO 2003/041722 |
| Date | 2003-05-22 |
| (30) | Number | Date | Country code |
| 01204323 | 2001-11-13 | EP |
| (72) |
LENSING, Anthonie Wilhelmus A., c/o N.V. Organon, NL
|
| (73) |
Aspen Global Incorporated,
GBS Plaza, Cnr. La Salette & Royal Roads, Grand Bay,
MU
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Fondaparinukso natrio specifinės dozės panaudojimas ūminių koronarinių sindromų gydymui |
| USE OF SPECIFIC DOSE OF FONDAPARINUX SODIUM FOR THE TREATMENT OF ACS |
| Payment date | Validity (years) | Amount | |
| 2021-10-26 | 347.00 EUR |